Micro
Developing
Active
BioCryst Pharmaceuticals, Inc. thèse haussière
Score
0,4
Vélocité
▲ 0,0
Articles
5
Sources
1
Résumé
An article belongs to this narrative if it presents a bullish thesis on BioCryst Pharmaceuticals, Inc. stock.
Articles Liés
Sources
Why BTIG Cut Its Target on Humacyte (HUMA) but Kept …
Yahoo Finance
This Cathie Wood Stock Is Down 36% Over the Past …
Yahoo Finance
Is This Stock a Buy on the Dip?
Yahoo Finance
BioCryst (BCRX) Rallies 7.10% on Acquisition Buzz
Yahoo Finance
Chronologie
Dernière mise à jour
Mar 21, 2026